XML 15 R6.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock
Treasury Stock, Common
Additional Paid-In Capital
Accumulated Other Comprehensive Income / (Loss)
Accumulated Deficit
Beginning Balance at Dec. 31, 2022 $ 489,686 $ 791 $ (47) $ 1,203,074 $ (357) $ (713,775)
Beginning Balance (in shares) at Dec. 31, 2022   79,123,312        
Issuance of common stock pursuant to exercise of stock options 1,114 $ 1   1,113    
Issuance of common stock pursuant to exercise of stock options (in shares)   88,429        
Issuance of common stock pursuant to vesting of restricted stock units   $ 1   (1)    
Issuance of common stock pursuant to vesting of restricted stock units (in shares)   126,060        
Issuance of common stock pursuant to exercise of warrants 7 $ 1   6    
Issuance of common stock pursuant to exercise of warrant (in shares)   126,093        
Issuance of common stock pursuant to the at-the-market offering program, net of issuance costs 17,222 $ 10   17,212    
Issuance of common stock pursuant to the at-the-market offering program, net of issuance costs (in shares)   948,300        
Unrealized comprehensive gain (loss) on investments 267       267  
Stock-based compensation 8,915     8,915    
Net loss (58,335)         (58,335)
Ending Balance at Mar. 31, 2023 458,876 $ 804 $ (47) 1,230,319 (90) (772,110)
Ending Balance (in shares) at Mar. 31, 2023   80,412,194        
Beginning Balance at Dec. 31, 2023 492,574 $ 903   1,450,722 319 (959,370)
Beginning Balance (in shares) at Dec. 31, 2023   90,282,267        
Issuance of common stock pursuant to exercise of stock options 1,184     1,184    
Issuance of common stock pursuant to exercise of stock options (in shares)   73,745        
Issuance of common stock pursuant to vesting of restricted stock units   $ 3   (3)    
Issuance of common stock pursuant to vesting of restricted stock units (in shares)   290,578        
Unrealized comprehensive gain (loss) on investments (454)       (454)  
Stock-based compensation 10,252     10,252    
Net loss (62,054)         (62,054)
Ending Balance at Mar. 31, 2024 $ 441,502 $ 906   $ 1,462,155 $ (135) $ (1,021,424)
Ending Balance (in shares) at Mar. 31, 2024   90,646,590